typ : |
noviny |
|
výzkumné týmy : |
Callaghan - School of Pharmacy and Medical Sciences |
Autor : |
Sharley NA, Yu AMC, Williams DB. |
titul : |
Stability of mixtures formulated from warfarin tablets or powder. |
Référence : |
J Pharm Pract and Res ; 37: 95-97. 2007 |
|
Úroveň důkazu : |
|
Fyzikální stabilita : |
|
chemická stabilita : |
|
jiné metody : |
|
Komentáře : |
|
Seznamy
Warfarin sodium
|
|
|
|
|
300 mg Coumadin® |
sodík fosfát |
3000 mg |
tragant |
4% 60 ml |
Sorbitol sirup |
5% 75 ml |
methylparabenu |
240 mg |
propylparaben |
60 mg |
propylenglykol |
3 ml |
destilovaná voda |
>> 300 ml |
|
20-24°C |
|
28 |
|
|
|
|
|
|
300 mg Marevan® |
sodík fosfát |
3000 mg |
tragant |
4% 60 ml |
Sorbitol sirup |
5% 75 ml |
methylparabenu |
240 mg |
propylparaben |
60 mg |
propylenglykol |
3 ml |
destilovaná voda |
>> 300 ml |
|
20-24°C |
|
28 |
|
|
|
|
Warfarin sodium clathrate
|
|
|
|
|
324.3 mg Warfarin sodium clathrate |
sodík fosfát |
3000 mg |
methylparabenu |
240 mg |
propylparaben |
60 mg |
propylenglykol |
3 ml |
destilovaná voda |
>> 300 ml |
|
20-24°C |
|
28 |
|
|
|
|
|